DE2117473A1 - Serodiagnostisches Präparat - Google Patents
Serodiagnostisches PräparatInfo
- Publication number
- DE2117473A1 DE2117473A1 DE19712117473 DE2117473A DE2117473A1 DE 2117473 A1 DE2117473 A1 DE 2117473A1 DE 19712117473 DE19712117473 DE 19712117473 DE 2117473 A DE2117473 A DE 2117473A DE 2117473 A1 DE2117473 A1 DE 2117473A1
- Authority
- DE
- Germany
- Prior art keywords
- human
- blood cells
- serodiagnostic
- preparation
- red blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 30
- 210000003743 erythrocyte Anatomy 0.000 claims description 29
- 102000001554 Hemoglobins Human genes 0.000 claims description 27
- 108010054147 Hemoglobins Proteins 0.000 claims description 27
- 241001465754 Metazoa Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 201000003068 rheumatic fever Diseases 0.000 claims description 12
- 210000002966 serum Anatomy 0.000 claims description 12
- 239000002504 physiological saline solution Substances 0.000 claims description 11
- 230000004520 agglutination Effects 0.000 claims description 9
- 101710186708 Agglutinin Proteins 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 101710146024 Horcolin Proteins 0.000 claims description 6
- 101710189395 Lectin Proteins 0.000 claims description 6
- 101710179758 Mannose-specific lectin Proteins 0.000 claims description 6
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims description 6
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 6
- 239000000910 agglutinin Substances 0.000 claims description 6
- 235000013330 chicken meat Nutrition 0.000 claims description 6
- 241000283707 Capra Species 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 5
- 239000000644 isotonic solution Substances 0.000 claims description 5
- 241000700198 Cavia Species 0.000 claims description 4
- 241000283086 Equidae Species 0.000 claims description 4
- 206010070834 Sensitisation Diseases 0.000 claims description 4
- 230000008313 sensitization Effects 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 108010006464 Hemolysin Proteins Proteins 0.000 claims 2
- 210000000601 blood cell Anatomy 0.000 claims 2
- 239000003228 hemolysin Substances 0.000 claims 2
- 238000013207 serial dilution Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3250070A JPS50893B1 (enrdf_load_stackoverflow) | 1970-04-16 | 1970-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2117473A1 true DE2117473A1 (de) | 1971-10-28 |
Family
ID=12360698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712117473 Pending DE2117473A1 (de) | 1970-04-16 | 1971-04-10 | Serodiagnostisches Präparat |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS50893B1 (enrdf_load_stackoverflow) |
| BE (1) | BE765893A (enrdf_load_stackoverflow) |
| DE (1) | DE2117473A1 (enrdf_load_stackoverflow) |
| DK (1) | DK126237B (enrdf_load_stackoverflow) |
| FR (1) | FR2099073A5 (enrdf_load_stackoverflow) |
| GB (1) | GB1345569A (enrdf_load_stackoverflow) |
| NL (1) | NL7105092A (enrdf_load_stackoverflow) |
| SE (1) | SE387174B (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2476320B1 (fr) * | 1980-02-15 | 1985-10-25 | Guffroy Rene | Nouveau reactif immunologique pour la detection en tubes du facteur rhumatoide dans un echantillon biologique et procede de preparation de ce nouveau reactif |
-
1970
- 1970-04-16 JP JP3250070A patent/JPS50893B1/ja active Pending
-
1971
- 1971-04-10 DE DE19712117473 patent/DE2117473A1/de active Pending
- 1971-04-15 SE SE492171A patent/SE387174B/xx unknown
- 1971-04-15 FR FR7113397A patent/FR2099073A5/fr not_active Expired
- 1971-04-15 DK DK178371A patent/DK126237B/da unknown
- 1971-04-15 NL NL7105092A patent/NL7105092A/xx unknown
- 1971-04-16 BE BE765893A patent/BE765893A/xx unknown
- 1971-04-19 GB GB2690171A patent/GB1345569A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE765893A (fr) | 1971-10-18 |
| SE387174B (sv) | 1976-08-30 |
| FR2099073A5 (enrdf_load_stackoverflow) | 1972-03-10 |
| JPS50893B1 (enrdf_load_stackoverflow) | 1975-01-13 |
| DK126237B (da) | 1973-06-25 |
| GB1345569A (en) | 1974-01-30 |
| NL7105092A (enrdf_load_stackoverflow) | 1971-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3590392C2 (enrdf_load_stackoverflow) | ||
| DE2202441B2 (de) | Barbitursäureantigene und spezifische Antikörper hierfür | |
| DE2707881C2 (de) | Verfahren zum Nachweis von rheumatoiden Faktoren | |
| DE2653032A1 (de) | Radioimmun-nachweisverfahren fuer ein schilddruesenhormon und dafuer geeignetes reagens | |
| CH627187A5 (enrdf_load_stackoverflow) | ||
| DE2805663A1 (de) | Verfahren zur herstellung von antigenen und antikoerpern | |
| DE2602997C2 (de) | Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung | |
| DE2900546C3 (de) | Verfahren zum Standardisieren einer markierten Bindungskomponente, welche in einem spezifischen Bindungstest-Verfahren mit einem Liganden reagiert, gegen einen Liganden-Referenzstandard und Verwendung der standardisierten markierten Bindungskomponente in spezifischen Bindungstest-Verfahren | |
| DE3105555A1 (de) | Reagens zum nachweis des rheumatoidfaktors, verfahren zu seiner herstellung und seine verwendung | |
| DE60035267T2 (de) | Verfahren zur analyse der menge an intraabdominalem fettgewebe | |
| DE2037507A1 (enrdf_load_stackoverflow) | ||
| DE2703523C2 (de) | Verdünnungsmittel für den Rubella- Virus-Hämagglutinations-Hemmungstest | |
| DE2934756C2 (de) | Zusammensetzung zur Bestimmung von beta 2 -Humanmikroglobulin und Verfahren zu deren Herstellung und deren Anwendung | |
| DE1617734B1 (de) | Verfahren zur Herstellung eines immunologischen Reagens | |
| DE2551576A1 (de) | Traeger fuer immunochemische messungen | |
| DE3887727T2 (de) | Partikelstabilisierte Epitope zur Standardisierung und Kontrolle von Immuntests. | |
| DE2814121C3 (de) | Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi | |
| DE2310280A1 (de) | Tubocurarin-antigene | |
| DE2117473A1 (de) | Serodiagnostisches Präparat | |
| DE2025718B2 (de) | Verfahren zum Stabilisieren von lyophilisierten Erythrozyten | |
| DE2555188C2 (de) | Verfahren zum Nachweis von Antigen oder Antikörper von infektiöser Hepatitis A in einer Probe | |
| DE2739038A1 (de) | Klonidin-test | |
| DE2703668C2 (de) | Verfahren zur Messung der Menge an Schilddrüsenhormon in einer Serumprobe | |
| DE2618449A1 (de) | Serumdiagnostische zusammensetzung | |
| DE2243237A1 (de) | Nachweis der immunreaktion gegenueber krebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHA | Expiration of time for request for examination |